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In situ telomere length analysis
Organotypic culture
Histone acetylationlength regulation in normal human tissues is still poorly understood. We show
here that telomerase is expressed in the epidermis in situ independent of age but was repressed upon the
passaging of keratinocytes in monolayer culture. However, when keratinocytes were grown in organotypic
cultures (OTCs), telomerase was re-established, indicating that telomerase activity is not merely
proliferation-associated but is regulated in a tissue context-dependent manner in human keratinocytes.
While not inducible by growth factors, treatment with the histone deacetylation inhibitor FK228 restored
telomerase activity in keratinocytes grown in monolayer cultures. Accordingly, CHIP analyses demonstrated
an acetylated, active hTERT promoter in the epidermis in situ and in the epidermis of OTCs but a
deacetylated, silenced hTERT promoter with subsequent propagation in monolayer culture suggesting that
histone acetylation is part of the regulatory program to guarantee hTERT expression/telomerase activity in
the epidermis. In agreement with the loss of telomerase activity, telomeres shortened during continuous
propagation in monolayer culture by an average of ∼70 base pairs (bp) per population doubling (pd).
However, telomere erosion varied strongly between different keratinocyte strains and even between
individual cells within the same culture, thereby arguing against a deﬁned rate of telomere loss per
replication cycle. In the epidermis in situ, as determined from early-passage keratinocytes and tissue
sections from different age donors, we calculated a telomere loss of only ∼25 bp per year. Since we
determined the same rate for the non-regenerating melanocytes and dermal ﬁbroblasts, our data suggest
that in human epidermis telomerase is a protective mechanism against excessive telomere loss during the
life-long regeneration.
© 2009 Published by Elsevier B.V.1. Introduction
The epidermis of the skin is a constantly renewing tissue that
requires tightly controlled mechanisms for maintaining tissue inte-
grity, to provide a life-long barrier against “inside out” water loss and
“outside in” attacks such as bacterial infection or damage by UV
radiation. The epidermis undergoes constant regeneration allowing
the elimination of damaged cells. This is achieved by proliferation of
the epidermal stem cells, giving rise to the so-called transit amplifying
cells, the actual proliferating cells in the basal compartment, i.e. the
stratum basale. After a few rounds of proliferation these cells
terminally differentiate and form multiple differentiated cell layers+49 6221 424551.
oukamp).
lsevier B.V.until they turn into dead horn squames that build the stratum
corneum. Additionally, melanocytes are also distributed throughout
the basal layer and are likely to play a role in protecting the stem cells
and proliferating basal cells.
The protective function of telomerase activity for telomere inte-
grity could be another potential regulator of epidermal integrity. The
human telomerase is a ribonucleoprotein reverse transcriptase com-
posed of two major components, the RNA component (hTR) which
functions as a template for adding new telomeric repeats, and the
catalytic subunit (hTERT). A number of additional proteins are also
required for the activation and inactivation of the complex [1–3].
While being active during embryogenic development, telomerase
expression is subsequently inhibited in many adult human tissues.
However, expression is maintained in regenerative tissues such as the
hematopoietic system and the gastrointestinal tract (for review see
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erative epidermis while the dermal ﬁbroblasts which only proliferate
rarely, e.g. upon wounding, are telomerase-deﬁcient [5,6]. This could
imply that telomerase is regulated in a proliferation-dependent
manner and would function in counteracting replication-dependent
telomere loss. However, it was reported that telomere length in skin
declines with age in a statistically signiﬁcant manner [7–10]. Since
this was also in agreement with data from telomerase knock out
studies [11], it was suggested that the level of telomerase observed in
normal human epidermis is insufﬁcient and thus functionally
inactive. Intriguingly, however, and despite the fact of a monthly
turn-over of the epidermis, the calculated rate of yearly telomere loss
was only about 25 bp thus arguing for a contribution of telomerase in
telomere length maintenance.
To better address the role of telomerase in human epidermis, we
have explored the consequences of telomerase activity on telomere
length regulation in the epidermis in situ and in keratinocyte cultures
in vitro. In agreement with our previous studies [2,5,12] we show that
telomerase is not constitutively expressed but that telomerase activity
can be detected when the keratinocytes have formed an epidermal
tissue (in the epidermis in situ an in organotypic cultures) but is
largely absent in monolayer cultures. Furthermore, we provide
evidence that histone acetylation is involved in this tissue context-
dependent regulation. In agreement with this differential telomerase
expression, also telomere length regulation differs in the epidermis in
situ and in monolayer culture arguing for telomerase as being
important for the life-long replication of the keratinocytes in human
skin.
2. Materials and methods
2.1. Culture conditions
Keratinocyte cultures were established from human foreskin
(infant and adult) or adult trunk skin (belly, breast, or upper leg, i.e.
sites generally not excessively exposed to UV radiation) – approved by
the Heidelberg Ethics Commission – and routinely passaged as
previously described [13]. In addition, foreskin keratinocyte cultures
from newborn donors were kindly provided by D. Spandau, Dept.
Dermatology, Indiana University, Indianapolis, USA. The cells were
propagated on lethally irradiated human feeder ﬁbroblasts [14] in FAD
medium containing 5% FCS and antibiotics [15] or grown in
keratinocyte growth medium (Epilife, Cascade Biologics, Clonetics,
Walkersville, USA) and split in a ratio of 1:3 to 1:5. The telomerase-
positive human HaCaT skin keratinocytes line was used as the control
[16]. Dermal human skin ﬁbroblasts were isolated from explant
cultures of human skin samples and routinely cultured as described
[17]. Peripheral blood leukocytes were isolated from blood by
standard procedures from individuals who all gave their consent for
isolating DNA and measuring their telomere length.
Growth factors (EGF, TGFα, GM-CSF, G-CSF, IL-6, KGF, all purchased
from R & D GmbH, Wiesbaden, Germany) were either dissolved in
DMSO or PBS and added to the culture medium at a ﬁnal
concentration of 10 ng/ml medium 24 h after plating. The cells were
incubated for 48 and 72 h with the addition of fresh growth factors
after 48 h. The deacetylation inhibitor FK228 (NSC630176) was
obtained from the Developmental Therapeutics Program (DTP) of the
National Cancer Institute (http://dtp.nci.nih.gov), and dissolved as a
stock solution in DMSO. Cells were treated at ﬁnal concentrations of
0.1, 1, 10, 100 and 250 ng/ml for 3, 6, 12, 24 and 48 h or 1 week. Control
samples were treated with an equivalent amount of DMSO.
2.2. Organotypic cultures (OTC)
Organotypic cultures of normal human keratinocytes were pre-
pared as described [18]. After 1 and 2 weeks cultures were preparedfor histology or TRAP assay. Histology was performed following
standard protocols. For the TRAP assay, the epithelia were separated
from the collagen substrate, frozen in liquid nitrogen and processed as
described in Bachor et al. [19].
2.3. Telomerase (TRAP) assays
Cell lysis of cultured cells and tissues and telomerase assay were
performed using the TRAPeze kit (Intergen Company, Oxford, UK, now
sold by Q-Biogene, Heidelberg, Germany). 50 ng of total protein
extract was used for each assay if not speciﬁed otherwise, and
speciﬁcity was veriﬁed by RNase-inactivation (RNase, DNase-free,
Roche, Mannheim, Germany) for selected samples. Products were
separated in non-denaturing 10% polyacrylamide gels, visualized by
auto radiography and PhosphorImager scanning (Fujiﬁlm Bas-1500),
and quantiﬁed with TINA 2.0 software.
2.4. Southern blotting
Genomic DNAwas prepared from peripheral blood monocytes and
keratinocytes using standard protocols. Five μg of DNA was digested
with RsaI (Roche, Mannheim, Germany) at 37 °C overnight and pro-
cessed as described [17]. Detectionwas performed using a CDP-Star kit
(Roche, Mannheim, Germany), image analysis with AIDA software
(version 2.0, Raytest Isotopenmeßgeräte GmbH, Straubenhardt,
Germany), and statistical analysis with Graph Pad Prism Version
3.00 (GraphPad Software, Inc., San Diego, CA, USA).
2.5. Quantitative ﬂuorescence in situ hybridization
Metaphases were prepared from normal keratinocytes and
HaCaT cells (control with a stable mean TRFL of 4 kb, [17]) using
standard protocols [20]. Quantitative Fluorescence in situ Hybridiza-
tion (Q-FISH) was performed with the Cy3-labeled telomeric PNA
probe Cat.-No. K5326 (DakoCytomation, Glostrup, Denmark) as
described [17]. Generally, 15 metaphases were analyzed per cell
type. Signals were quantiﬁed with the Telomere Quantiﬁer Software
(DakoCytomation, Glostrup, Denmark). Telomere lengths (in kb) of
the keratinocytes were calculated by mathematical equation to the
4 kb mean telomere length of the HaCaT cells.
2.6. Western blot analysis
Cell pellet preparation and further processing were performed as
described [20]. Antibodies used were: anti-acetyl-H3, -acetyl-H4, or -
acetyl-Lys (# 06-911, # 06-598, and # 21873, Upstate, Wolverton Mill
South, UK), anti-histone H3 (ChIP Grade, ab1791, Abcam), and
horseradish peroxidase-coupled secondary antibody (Dianova, Ham-
burg, Germany). Protein bands were detected using the enhanced
chemiluminescence detection kit (Amersham-Pharmacia Biotech,
Freiburg, Germany).
2.7. Chromatin precipitation (CHIP) analysis
CHIP was performed as described by Santoro and Grummt [21]. In
brief, feeder cells were removed by short-term trypsin treatment, the
keratinocytes were ﬁxed with formaldehyde (1%) for 15 min at 37 °C,
collected by scraping. and centrifuged. Cell pellets were resuspended
in 460 μl Chip-dilution buffer (Upstate), and the DNAs were sheared
and sonicated. The cell lysates were then precleared with protein A-
agarose beads and incubated with anti-acetyl-histone H4 (Upstate #
06-866) antibody over night at 4 °C. The DNA–protein complexeswere
eluted with elution buffer (Upstate) for 2 h at 37 °C, followed by 65 °C
over night. The complexes were then puriﬁed with phenol-chlor-
ophorm, precipitated with ethanol and resuspended in ddH2O. PCR
was performed with primers: GGC CGG GCT CCC AGT GGA TTC G
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at 96 °C, 30 cycles of 30 s at 96 °C, 30 s at 58 °C, and 2min at 68 °C and a
ﬁnal 6 min at 68 °C. The PCR products were fractionated on a 2%
agarose gel. HaCaT cells were used as a positive controls and no
antibody and histone 3 antibody (# 06-911, Upstate); not recom-
mended for immunoprecipitation, as negative controls. To identify
human keratin 16 (hK16) the following primers were used: AAA GCT
GGG TGG GAA CTC TGA GCC (forward) and GGT GCC AAG GAG GGA
GGT GAG C (reverse) for 5min at 96 °C, 25 cycles of 30 s at 96 °C,1 min
at 58 °C, 1 min at 68 °C and a ﬁnal 6 min at 68 °C.
2.8. RNA isolation and RT-PCR analysis
Total RNA was isolated from OCT-frozen tissue sections or from
dermal equivalents using RNeasy according to manufacturer's ins-
tructions (Qiagen Hilden, Germany). One μg of total RNA from each
sample was reverse transcribed to cDNA (Omniscript, Qiagen) as
described in detail previously [22]. The cDNA template was used in a
PCR reaction with the conditions and primers for hTERT and GAPDH
as described [22].
2.9. 3D FISH analysis on skin sections
Simultaneous immunoﬂuorescence/FISH analysis. Cells directly
grown on glass slides or 5 μm skin cryostat sections were ﬁxed in
3.7% formaldehyde for 15 min, washed, permeabilized with 0.2%
Triton X-100, rinsed in ddH2O, and air-dried. Cy3-labeled PNA probe
(PNA Telomere FISH Kit K5326; DAKO A/S, Lustrum, Denmark) was
added before denaturing the DNA for 3 min at 80 °C. After hybri-
dization (2 h at 30 °C) the slides were washed at room temperature
(rt) with 70% formamide/10 mM Tris–HCl, pH 7.2 (2×20 min), PBS
(1 min), 0.1×SSC for 5 min at 55 °C, and PBS containing 0.05% Tween-
20 (2×5 min at rt), and rinsed in ddH2O. The slides were then shortly
air dried, and incubated for 2 h at rt with an anti-keratin (DAKO
Corporation, Carpinteria, CA, USA, dilution of 1:1000) and anti-
vimentin antibody (Progen, Heidelberg, Germany, dilution 1:50).
After washing with PBS, the slides were incubated with Cy2-
conjugated anti-rabbit and AMCA-conjugated anti-guinea pig anti-
bodies (Jackson ImmunoResearch Laboratories Inc., USA, at a dilution
of 1: 50) 45 min at rt, washed with PBS, and covered with antifade
solution (VectaShield, Vector Laboratories Inc., Burlingame, CA).
Alternatively, telomere hybridization was counterstained with DAPI
and combined with DTAF-conjugated anti-guinea pig antibody.
3D image acquisition, deconvolution microscopy, and image proces-
singwere principally performed as described [23] with a modiﬁcation
of the automation program (OpenLab software package) allowing
deconvolution of N30 image stacks over night. Deconvolution of Cy3,
Cy2, DAPI, AMCA and DTAF signals were performed individually with
the same conditions for a given ﬂuorochrome. The deconvolved
images (stack of TIFF images) were further used for 3D reconstruction
with Amira 3D visualization software (version 3.0, Indeed-Visual
ConceptsGmbH, Berlin), and for telomeric signal intensity determina-
tion using ImageJ software (version 1.33u, Wayne Rasband, National
Institutes of Health, USA).
3D reconstruction of telomeres (Cy3 emission, pseudo-colored in
red) was performed by using the Amira module that computes an
isosurface within a 3D scalar ﬁeld. In addition, keratin (Cy2 and
emission, in green), nuclei (DAPI emission, in blue), and vimentin
staining (AMCA emission, in blue, or DTAF in green) were visualized
with the Amira ProjectionView module; computing shadow projec-
tions of 3D images onto the three major planes (xy, xz, yz).
Quantiﬁcation of the digitized ﬂuorescent telomere signals was
accomplished by using an ImageJ maximum Z Projection of
deconvolved images. Projected telomeric signal intensities (TSI)
with sizes greater than the threshold (background noise) were
measured. Intensities for each telomeric spot were tabulated andexported to Microsoft Excel (Microsoft Corp.). GraphPad Prism
(GraphPad Software, San Diego California, USA) was used for
further data handling and statistical analysis. Statistical signiﬁcance
was determined using t test with a signiﬁcance level of p=0.05
(⁎0.01bpb0.05, ⁎⁎pb0.01). For telomere shortening, linear regres-
sion and signiﬁcance of deviation from zero were measured. A
control skin sample with known TSI was included in each
experiment. Analyses of the same regions on serial skin sections
and co-hybridization with a centromere 7-speciﬁc PNA probe were
used to conﬁrm hybridization efﬁciency. All experiments were
repeated at least twice.
To recalculate TSI into telomere length in kb, TSI of HaCaT, HaCaT-
myc, human-, and mouse A9 ﬁbroblasts were calculated and plotted
against the TRFL values determined from the same cell populations
by Southern Blot analysis. Chemilumi image exposures were digitized
and transferred to Microsoft Excel, and were the basis for calculating
the mean TRFL using the formula: TRFL=Σ(ODi)/Σ(ODi/Li) where
ODi is the integrated signal intensity at position i, and Li — the length
of DNA fragment in position i. Calibration curves established this way
were used for telomere lengths determination in skin sections.
2.10. Time lapse microscopy
To analyze telomere shortening on the single cell level passage 4
keratinocytes (∼13 pd) were plated in keratinocyte growth medium
(Dermalife, Lifeline Cell Technology, USA) in a slide ﬂask (Nunc, Kat.
Nr. 170920, Germany). After cell attachment, the ﬂasks were tightly
sealed (to keep CO2 levels constant), and placed in the temperature-
controlled incubator (37 °C) of the inverted microscope (Axiovert
S100 TV, Carl Zeiss MicroImaging Inc., Germany). Live cell microscopy
was performed at a low magniﬁcation (10X) and phase-contrast
images (850×680 μm) were captured every 6 min for 92.8 h. At the
end of monitoring, stacks of 929 images were exported to ImageJ
program and used for further analysis. Each cell in this sector was
labeled with a number (1,2,3….). After the each cell division, the two
daughter cells were further labeled (1-1/1-2, 2-1/2-2 …). Each
individual cell was followed for its next mitosis, allowing for the
measurement of the number of mitoses and cell cycle times for each
individual cell. After 92.8 h the cells were ﬁxed and stained for
telomeres (see above). 46 3D images of the monitored region were
taken (63× objective) and the mean telomere signal intensity was
measured and expressed in kb for each cell from themonitored region.
Altogether 403 cells were monitored.
3. Results
3.1. Telomerase activity varies in keratinocytes from different donors
To study telomerase regulation in more detail we established
keratinocyte cultures from 23 epidermal isolates (15 trunk skin and
8 foreskin samples) from different-age donors, including 5 samples
from newborn foreskin, and determined their telomerase status by
TRAP assay. As shown in Fig. 1A, TRAP activity in the different
samples varied signiﬁcantly from low to high levels with a few
samples showing an activity comparable to or only slightly less
than that of the immortal HaCaT skin keratinocytes, which were
used as control for cells with high telomerase activity [22] (Fig.
1B). Most importantly, telomerase activity was not elevated in the
newborn foreskin samples (Fig. 1C). Thus, our ﬁndings indicate that
the expression level of telomerase is independent of donor age.
3.2. Telomerase activity is rapidly down-regulated in monolayer
culture in vitro
To determine how proliferation inﬂuences telomerase activity, six
keratinocyte strains were propagated in culture until they reached
Fig. 1. Telomerase is expressed in early-passage keratinocytes but downregulated with further propagation in monolayer culture. (A) Telomerase activity was determined by
TRAPeze assay in ﬁrst passage keratinocytes from different-age donors all being telomerase-positive though exhibiting different levels of telomerase activity. HaCaT cells (H)
serve as positive control and HaCaT cells treated with RNase, ﬁbroblasts, and dilution buffer as negative control. (B) In a titration experiment dilutions of 1:50 (50), 1:25 (25),
1:10 (10), 1:5 (5) and undiluted (1) HaCaT extracts were compared with undiluted extracts from two normal keratinocyte strains thereby showing that telomerase levels in
the normal cells can be as high as in the immortal keratinocytes. HaCaT extracts were diluted with extracts from telomerase-negative ﬁbroblasts to guarantee similar protein
concentrations. (C) Also second-passage keratinocytes from ﬁve (1 to 5) newborn (N) foreskin exhibit different levels of telomerase activity. HaCaT cells (H) serve as positive
and HaCaT cell treated with RNase (H+) as negative control. (D) During further propagation in monolayer culture telomerase activity declines with increasing passage number
(pc=primary culture, 1, 3, 9, and 11=passage number). (E) Only freshly isolated or primary culture keratinocytes exhibit good levels of hTERT expression (RT-PCR).
Expression of GAPDH is used as a loading control. Data from two individual keratinocyte strains are shown. The ﬁrst represents: freshly isolated cells (1) and passage 3 (2), 5
(3), and 7 cells (4), the second one: intact epidermis (5) freshly isolated keratinocytes (6) and cells from passage 3 (7) primary culture (8) and passages 2 (9) and 4 (10).
RNA from HaCaT cells (11) served as a positive control.
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which primarily exhibited high levels, telomerase activity declined
within ∼10 pd (Fig. 1D). In the other two strains that only exhibited
low levels in early passage cultures, telomerase activity became
undetectable even more rapidly (data not shown).
To determine how the culture-dependent telomerase inhibition
was regulated, we next investigated hTERT expression by RT-PCR and
found that hTERT mRNA was strongly reduced (Fig. 1E). This
suggested that telomerase activity was inhibited in monolayer
cultures by transcriptional silencing of the hTERT gene.
3.3. Telomerase activity cannot be restored by conventional culture
conditions
Despite telomerase inhibition, all keratinocytes continued to pro-
liferate in monolayer cultures for another 20 to 30 population
doublings (pd), demonstrating that proliferation per sewas not causalfor telomerase expression. However, it is well established that
keratinocyte growth and differentiation in the epidermis in situ is
promoted through speciﬁc growth factors induced upon mutual
interaction of the keratinocytes with the underlying dermal ﬁbro-
blasts [24–26]. One of these factors is EGF which has been shown
earlier to activate hTERT expression upon binding to the ets binding
site in the hTERT promoter [27]. Interestingly, neither co-cultivation of
the keratinocytes with ﬁbroblast feeder cells [14], nor propagating
them in keratinocyte growth medium containing a set of growth
factors (including EGF) was able to maintain telomerase activity. To
exclude that speciﬁc factors were missing or were present in
insufﬁcient amounts, we further propagated three keratinocyte
strains in the presence of 10 mM/ml EGF/TGFα, IL-6, G-CSF, GM-
CSF, and KGF, applied either individually or in combination. Cells were
harvested after 48 h and 72 h and assayed for telomerase expression
analyses but none of these factors was able to re-stimulate telomerase
expression in monolayer cultures (Fig. 2A).
Fig. 2. Telomerase is re-expressed in culture when the keratinocytes are allowed to form an epidermis-like epithelium. (A) Growth factors cannot overcome the culture-dependent
telomerase inhibition. TRAPeze detection of telomerase activity 48 h after growth factor treatment. 1=control, 2=EGF/TGFα, 3=IL-6, 4=GM-CSF, 5=G-CSF, 6=KGF. HaCaT cells
(H) are used as a positive control and HaCaT cell lysates treated with RNase (H+), telomerase-negative human skin ﬁbroblasts (F) as negative controls. IC=internal 36 bp standard.
(B) Keratinocytes were grown in organotypic cultures (on a collagen gel with integrated ﬁbroblasts and air exposed). H & E staining of a two-week-old culture showing a stratiﬁed
and well-differentiated epidermis. (C) TRAPeze detection of telomerase activity in a keratinocyte strain that was propagated in conventional cultures and analyzed at passages (p) 1,
3, and 5, shows a clear decline in telomerase activity. 3rd passage keratinocytes from this strain were grown in OTCs and re-express increased levels of telomerase activity.
IC=internal 36 bp standard; bar=30 μm.
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human keratinocytes
Onemajor difference between the co-culture of keratinocytes with
feeder ﬁbroblasts and growth of the keratinocytes in the epidermis in
situ is their three-dimensional organization within the tissue. In
addition to the multilayered nature of the epidermis, the basal cells,
tightly connected to the basement membrane, exhibit a cuboidal
morphology as compared to their largely ﬂattened cell shape observed
in monolayer culture. This determines cell polarity and most likely an
altered sensitivity towards activating or inhibiting factors provided by
the dermal ﬁbroblasts.
To address the role of tissue organization, we performed orga-
notypic cultures (OTCs) with 2nd and 4th-passage keratinocytes
being plated on a dermal equivalent that consisted of a collagen type I
gel containing human dermal ﬁbroblasts. Within two weeks the
keratinocytes formed a three-dimensional tissue with all the
characteristics of a stratiﬁed epidermis (Fig. 2B). Most importantly,
telomerase activity was absent or only faintly expressed in monolayer
cultures but was clearly detectable in keratinocytes grown in the OTCs
(Fig. 2C). This result was conﬁrmed with a second independent
keratinocyte strain (data not shown).
3.5. Histone acetylation/deacetylation is part of the regulatory program
of telomerase activity in human skin keratinocytes
One possible explanation for the absence of hTERT expression after
addition of e.g. EGF in monolayer cultures could be that the hTERT
promoter might not be accessible. Epigenetic modulation, i.e. DNA
CpG-methylation and histone acetylation, known to modulate the
chromatin state, have previously been show to modify hTERT/telo-
merase expression [28]. Furthermore, histone deacetylation inhibitors
reactivated telomerase in a number of cell types [29–32].
Therefore, we treated the keratinocytes in monolayer cultures
with the histone deacetylase inhibitor FK228 (now known as
romidepsin) (for reviews see [33,34]) and measured TRAP activity
after 3, 6, 12, and 24 h. As shown in Fig. 3A, telomerase activity
recurred in a time-dependent manner with maximal activity at 24 h
(Fig. 3A). Neither increasing concentrations of FK228 (here shown for250 ng/ml) nor combining FK228 with EGF did enhance the level of
telomerase activity further (data not shown), suggesting that at
100 ng/ml of FK228 was sufﬁcient to completely inhibit deacetyla-
tion and thus maximally stimulate telomerase activity in the
keratinocytes. Interestingly, repeated treatment with 100 ng/ml
FK228 – in order to maintain telomerase activity for long-term
growth in monolayer cultures – caused differentiation of the cells
within one to two weeks (data not shown). Even with reduced
concentrations (≤0.1 ng/ml) the cultures terminally differentiated
within the following weeks. Thus, long-term treatment with histone
deacetylation inhibitors and with that global inhibition of deacetyla-
tion is incompatible with continuous proliferation and not a useful
experimental approach to maintain telomerase activity in cultured
(monolayer) keratinocytes. Dermal ﬁbroblasts, telomerase-negative
in monolayer culture as well as in the skin in vivo [5], did not become
telomerase-positive under these treatment conditions (see Fig. 3A),
indicating that hTERT activation in ﬁbroblasts requires alternative/
additional regulatory steps.
Since the deacetylation inhibitor FK228 was able to reactivate
telomerase, we reasoned that histones were predominantly deacety-
lated in monolayer cultures but became acetylated upon FK228
treatment. To test this, we performed Western Blot analyses with
keratinocytes before and 24 h after treatment with FK228 by using
antibodies that speciﬁcally recognize acetylated histones (anti-
acetylated histones H3 and H4 as well as an antibody recognizing
the acetylated lysines in all histones). All three antibodies showed
little or no acetylation in the untreated keratinocyte cultures but
increased acetylation after a 24 h treatment with FK228 (Fig. 3B). This
was not due to changes in histone expression per se, as the overall
level did not change (Fig. 3D).
3.6. Histone acetylation correlates with tissue-dependent telomerase
activity in the epidermis
To determine whether histone acetylation may also be responsible
for the shift in telomerase expression in the epidermis in situ versus
keratinocytes in monolayer cultures, we compared the acetylation
proﬁle of keratinocytes freshly isolated from the epidermis versus 3rd
passage keratinocytes and found a similar difference in histone
Fig. 3. Histone deacetylation is involved in telomerase regulation. (A) The histone acetylase inhibitor FK228 can reactivate telomerase in the cultured keratinocytes (K) but not
in dermal ﬁbroblasts (F). Cells were treated with FK228 (100 and 250 ng/ml) and telomerase activity (TRAPeze assay) was determined after 6, 12, and 24 h. An untreated lysate
from HaCaT cells (H) served as positive and RNase treated HaCaT cells (H+) as negative control. IC=internal 36 bp standard. (B–D) Western blot analyses demonstrate
differences in histone acetylation using different histone antibodies (antibody recognizing all acetylated lysines (ac-L) and antibodies against the acetylated histones 3 (ac-H3)
and histone 4 (ac-H4)). (B) Comparison of cultured keratinocytes without (−) and with (+) FK228 treatment and (C) comparison of keratinocytes freshly isolated from the
epidermis (in vivo=ﬁ) versus cultured 3rd passage keratinocytes (in vitro=c). For all three antibodies the same cell combination is shown. (D) As a control, non-acetylated
histones are present in similar amounts in the absence (−) and presence (+) of FK228 as well as in vivo (ﬁ) and in vitro (c). (E–G) Chromatin immunoprecipitation study
(CHIP) for hTERT and keratin 16 promoter DNA precipitated with an anti acetyl histone 4 antibody to investigate (E) different keratinocyte passages (passages 1, two
independent samples from passage 3, and passage 4 cells). HaCaT cells served as a positive control, and an irrelevant antibody (anti TRF2 antibody) as a negative control. (F)
CHIP analysis performed with DNA isolated from keratinocytes grown in organotypic culture (O) and HaCaT cells (H) (positive control). PCRc is a PCR positive control. (G) CHIP
analysis of epidermal isolates and cultured keratinocytes (passage 1 and 4) and HaCaT cells (H) analyzed for human keratin 16 (hK16) promoter DNA. 10% of the primary
solution was used as input DNA in F and G.
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The freshly isolated keratinocytes showed distinct bands with the
three different antibodies while essentially no bands were seen with
3rd-passage keratinocytes.
To conﬁrm the role of histone deacetylation (and by analogy
chromatin compaction) on hTERT promoter inhibition, we performed
chromatin precipitation studies (CHIP) with different passage kera-
tinocytes. While hTERT promoter fragments from ﬁrst-passage
keratinocytes precipitated with an antibody speciﬁc for the acetylated
histone 4 (acetyl H4), the amount of hTERT fragments decreased with
further propagation in monolayer culture and could no longer be
detected at later passages (Fig. 3E). This result was conﬁrmed with a
different keratinocyte strain (data not shown) suggesting that
deacetylation-dependent silencing of the hTERT promoter was not
unique for a speciﬁc keratinocyte population.
If acetylation/deacetylation was involved in telomerase regulation
in the epidermis in situ and in monolayer culture, reactivation of
telomerase in organotypic cultures should require hTERT promoteracetylation. Indeed, CHIP analysis demonstrated the presence of
acetylated hTERT promoter fragments in the epidermis formed in
organotypic cultures (Fig. 3F). As a gene known to be actively
transcribed both in the regenerating epidermis in situ and in mono-
layer culture, we also investigated for keratin 16 promoter acetyla-
tion and found no changes (Fig. 3G), further strengthening the
speciﬁcity of hTERT promoter deacetylation for the inhibition of
telomerase activity.
3.7. Telomere length declines in a replication-dependent manner during
propagation in monolayer cultures
Although it was suggested that telomerase activity of human
keratinocytes would be insufﬁcient to counteract telomere erosion,
our ﬁnding that telomerase was only detectable when keratinocytes
they had formed an epidermis but not when they were grown in
monolayer cultures prompted us to determine whether telomere
shortening in monolayer culture would correlate with a more promi-
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the epidermis regenerates every three to four weeks and accordingly,
also the stem cells should also go through a number of replications
per year.
To address this, we ﬁrst propagated different keratinocyte strains
up to cellular senescence and investigated their telomere lengths at
different passage levels by determining their telomere restrictionfragment lengths (TRFL). Two keratinocyte strains derived from
infant foreskins, exhibited an initial mean TRFL of about 10 kilobases
(kb) and senesced after N30 pd with a mean TRFL of 6 to 7 kb, giving
rise to a calculated loss of 100 to 130 bp per pd (one example is
shown in Fig. 4A, left panel). Keratinocytes derived from an adult
foreskin or from different sites of trunk skin, on the other hand,
varied strongly in their rate of telomere loss, ranging from 18 to
125 bp per pd (one example is shown in Fig. 4A, right panel). A
similar variation was observed when performing Q-FISH analysis
(Fig. 4B and C). Altogether these data argue for a telomeric loss of
∼100 bp per pd for the keratinocytes when being propagated in
monolayer cultures.
While this average estimate already implicated major variations
between different keratinocyte populations, we aimed for establishing
the rate of telomere loss in individual keratinocytes. For this, kera-
tinocytes were plated at low density and followed by live cell imaging
over a period of 92.8 h. Individual cells weremarked and after mitoses
the two daughter cells were followed for further replication. Those
daughter cells that differed in their subsequent replication number
where chosen for telomere length measurement. Telomere length
measurements were performed by in situ hybridization of the
telomeres with a telomere-speciﬁc PNA probe, deconvolution micro-
scopy, 3D-telomere reconstruction [23,35]. Measurement of the
individual signal intensities was performed and the mean of all telo-
meres per nucleus was then compared for each “daughter pair”.
Being able to identify 14 daughter pairs that differed in at least one
replication round (2/14 differed in 2 and 1/14 differed in 3) we found
an unexpected heterogeneity (Fig. 5). First, most but not all daughter
cells remained synchronized in their replication time. Second, the cell
cycle time varied from 12 to 35 h between different daughter pairs and
third, telomere erosion varied from 45 to 1044 bp with no obvious
correlation between the rate of telomere loss and cell cycle time.
These results implicate that even within the same keratinocyte
population there is no deﬁned rate of replication-dependent telomere
loss.
3.8. Telomere length heterogeneity rather than an age-dependent decline
is characteristic for early-passage human skin keratinocytes
To determine telomere length regulation in human epidermis in
situ we measured the mean TRFL from 31 early passage keratinocyte
samples from donors ranging from newborn (0 year) to the age of 89.
The six newborn foreskin samples showed a homogeneous distribu-
tion with a mean TRFL of 9 to 10 kb (Fig. 6A). The samples from the
infant and adult donors (3 foreskins and 22 trunk skins), on the other
hand, differed (Fig. 6B). Instead of a steady age-dependent decline,
these samples showed strong inter-individual telomere length
heterogeneity with differences ranging from 11 to 5 kb. Interestingly,
the largest differences were seen in the group of 30 to 50 years while
variations were less pronounced in samples from older donors
(≥60 years) and the oldest donor (89) actually showed a similar
mean TRFL as the youngest donors with 10 kb. From these data we
calculated decline of ∼25 kb loss per year and this decline was not
statistically signiﬁcant (pvalue of 0.1027; Fig. 6C).Fig. 4. Telomere lengths decrease with consecutive propagation of human skin kera-
tinocytes in monolayer culture. (A) Telomere-speciﬁc Southern blot from keratinocytes
isolated from the epidermis of an infant (age 1, left panel) and an adult donor (age 24,
right panel) and cultured up to cellular senescence. Different passages were analyzed
for TRFL. Mouse A9 cells with a mean TRFL of ∼11 kb were used as a control. (B)
Fluorescence in situ hybridization (FISH) images of metaphase spreads from an early
and late passage of infant keratinocytes (pds 3 and 27, lower panel) and adult (pds 3
and 15, upper panel), respectively. Yellow: telomeric FISH signals and blue: DAPI
counterstained chromosomes. (C) Quantitative FISH (Q-FISH) analysis from keratino-
cytes from, foreskin from a 3-year-old donor (pds 3, 12 and 27), trunk skin from a 75-
year-old donor (pds 3, 10, and 15) and foreskin from a 33-year-old donor (pds 3, 12 and
18). Each curve represents the mean of at least 10 metaphases.
Fig. 5. Telomere loss differs between individual cells of the same population. Live cell
microscopy combined with 3D-telomere length measurement was used to identify
telomere length between different daughter cells (A) phase contrast micrographs of the
keratinocyte cultures at the start (24 h after plating — time point 0) and (B) at the end
(time point 92.8 h) of the live-cell-imaging experiment. (C) In a given area each mitosis
was marked with a speciﬁc number and the daughter cells were followed and marked
againwhen theywent through the nextmitosis. (D) Same area after in situ hybridization
with the telomere-speciﬁc PNA probe (DakoCytomation, Glostrup Denmark) in red.
Nuclei are counterstainedwith DAPI (in blue). (E) In 14 daughter pairs that differed in at
least one replication round we found an unexpected heterogeneity, telomere erosion
varied from 45 to 1044 bp. The mean telomere length and the error of mean are shown
for cells from each replication round as well as the linear regressions between the
replication rounds. The differences between the different regression slopes were not
statistically signiﬁcant (p=0.2665), therefore, one slope could be calculated for all 14
cells — corresponding to a telomere loss of 322 bp/division.
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minimal age-dependent decline
Since establishing keratinocytes in culture may represent selection
for speciﬁc subpopulations, we next adapted our 3D telomeric FISH
analysis for telomere length analysis on tissue sections and combining
it with immuno-labelling, we evaluated telomere length of the
epidermal keratinocytes in skin samples from 12 different donors
(ranging from 2 to 81 years of age). In addition, this technique allowed
the distinction between the different cell types, i.e. keratinocytes,
melanocytes, and ﬁbroblasts present within the same skin section
(Fig. 7A).
We ﬁrst investigated the telomere lengths for the epidermal
keratinocytes. Their respective mean lengths integrated well into the
age-dependent pattern seen by Southern blot analysis (Fig. 7B and
see Fig. 6C diamonds). Accordingly, combining all data and calcula-ting their linear regression, we now obtained a statistically signiﬁcant
(p-value of 0.0181) yearly loss of 25 bp.
3.10. Epidermal differentiation does not contribute to telomere loss
To determinewhether and how differentiationwould contribute to
telomere length regulation, we next studied samples from 14 different
donors by dividing the epidermis into basal, suprabasal, and upper
part (as indicated in Fig. 7C) and measured telomere length in at least
5 individual areas of each specimen (Fig. 7D). We found one sample
with both suprabasal und upper part containing shorter telomeres
than the basal layer, one sample with the upper layers containing
shorter and two where the upper layers contained slightly longer
telomeres. In most (10/14) samples, however, telomere lengths were
very similar in all planes, indicating that epidermal differentiation
does not contribute to telomere loss.
3.11. Telomere length maintenance is a characteristic of human skin
Since the in situ technique allowed us to distinguish between
different cell types within the same skin sample, we also investigated
for telomere length of the non-epidermal cells, the melanocytes,
which make up ∼10% of the basal layer of the epidermis, and the
ﬁbroblasts which reside in the underlying dermis. It is important to
note that different from the epidermal keratinocytes both cell types
only rarely proliferate in intact skin. As shown in Fig. 7B, for each
individual tissue sample, telomeres were longer in the ﬁbroblasts and
melanocytes as compared to the respective keratinocytes. Actually,
both cell types (within the same sample) exhibited highly comparable
telomere lengths and unexpectedly, all three cell types (keratinocytes,
ﬁbroblast, and melanocytes) revealed very similar and statistically
non-signiﬁcant regression slopes (epidermis: p-values of 0.0907,
dermal ﬁbroblasts: p-value of 0.1972, and melanocytes p-value of
0.0886) (see Fig. 7B).
Finally and as a control for a different proliferation-active tissue,
we also investigated hematopoietic cells, i.e. peripheral blood
lymphocytes (PBL). It is well accepted that PBLs exhibit age-
dependent telomere attrition [36] and in agreement with these
previous data, we found a statistically signiﬁcant reduction with a
p value of 0.0010 when establishing the mean TRFL for PBLs from
different-age donors (Fig. 7F).
4. Discussion
4.1. No signiﬁcant age-dependent telomere loss of keratinocytes in
human epidermis in situ
The epidermis, as the outermost barrier of the human body
depends on mechanisms that guarantee life-long tissue integrity. One
of these mechanisms is its constant regeneration which allows for a
steady elimination of “damaged” cells from the basal proliferative
compartment by passing through a deﬁned program of differentiation
and desquamation as dead horn squames. This continuous regenera-
tion, however, also bears the risk of constant telomere shortening
and, therefore, exhaustion of the proliferative potential of the
epidermis in aged skin due to critically short telomeres. Indeed,
evidence existed for a signiﬁcant age-dependent decline in telomere
length for peripheral blood lymphocytes ([37]; for review see [38]) as
well as human skin [7–10]. However, in contrast to blood lympho-
cytes, the rate of telomere loss in human epidermis or in complete
skin was small with a range of 9 to 36 bp/year. Only one study
reported on a rate of 75 bp/year [8]. Our data conﬁrm the signiﬁcant
rate of age-dependent telomere loss in blood lymphocytes. Here it is
noteworthy that our PBL samples were derived from members of two
related families, thus restricting genetic differences. Our data also
support the low rate of telomere loss in human epidermis, thereby
Fig. 6. Telomere length heterogeneity not telomere loss characterizes human skin keratinocytes from different-age-donors. (A–B) Telomere-speciﬁc Southern blot analysis of six
second-passage foreskin keratinocyte strains from newborn donors (last lane=HaCaT cells) (A), and freshly isolated or ﬁrst passage culture keratinocytes from different-age-donors
(ﬁrst lane=HaCaT cells) (B). (C) Quantiﬁcation of the mean TRFL with indicated donor age. Linear regression of the 31 samples (black circles) demonstrates lack of statistical
signiﬁcance (pvalue of 0.1027) for age-dependent telomere attrition in the human skin keratinocytes. Grey diamonds represent the data obtained from the 3-dimensional telomere
length analysis on tissue sections from different-age donors (see Fig. 7).
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maintenance between these two tissues.
We further demonstrate that in the same skin sections where we
measured telomere length of keratinocytes, the ﬁbroblasts in the
dermis and the melanocytes within the basal layer of the epidermis
both exhibit longer telomeres and a similar minor age-dependent
regression rate (see Fig. 7B). This ﬁnding is in good agreement with
TRFL data from Sugimoto et al. [10] reporting on longer telomeres in
the dermis than the epidermis and a regression rate of 11 bp/year
for the dermis and 9 bp/year for the epidermis. Although only a few
samples were available from very young donors so far, the difference
in telomere length between epidermal keratinocytes versus dermal
ﬁbroblasts and melanocytes already seemed to be established early
in life. If this is correct and provided that the different cell types
start with a similar telomere length, these results implicate a rapid
telomere loss during early epidermal development, i.e. a phase when
even epidermal stem cells are supposed to proliferate heavily.
During this time, apparently, telomerase is not sufﬁcient for
telomere length maintenance. Thereafter, when proliferation is
restricted to maintaining tissue homeostasis, however, the level of
telomerase seems adequate to minimizes telomere erosion to a
similar rate as seen in the non-regenerating cells, i.e. to only a few
bp per year.
A rapid telomere loss was described for PBLs of young children
(N1 kb per year) followed by an apparent plateau between the age of
four and young adulthood and gradual attrition later in life [37]. The
authors proposed that loss of telomeric repeats in hematopoietic cells
is a dynamic process that is differentially regulated in young childrenand adults. Besides a potential rapid telomere loss discussed for the
embryogenic development, we did not detect obvious phases of telo-
mere attrition in the human epidermis thereafter. It is intriguing to
note that all three skin cell types exhibit a similar rate of telomere loss.
Considering the fact that ﬁbroblasts and melanocytes hardly ever
proliferate, it is tempting to suggest that the rate of 11 bp/year
reported by Sugimoto [10] and ∼25 bp/year determined here, may not
even be proliferation-related. If so, the more this argues for active
telomere lengths maintenance throughout life time of the constantly
proliferating keratinocytes. Along this line, Counter et al. [39] found
that in patients with severe burns the epidermal transplants derived
from keratinocytes expanded in monolayer cultures had shorter
telomeres than in non-cultured skin transplants from the same
individuals or those in skin of healthy donors older than 80 years.
From this they concluded that due to the great loss of telomeric DNA
the engrafted cells might have a shortened lifespan, which could have
negative repercussions on the long-term viability of these grafts.
Having now shown that telomerase is inhibited in culture but can be
reactivated in cells that are allowed to form an epidermal tissue, such
concerns may be invalid since in the tissue context telomerase may be
reactivated and protect against consecutive severe telomere attrition.
This said, it is tempting to suggest that intrinsic skin aging occurs
rather independently of telomere shortening. The mechanism how
telomere length is maintained, however, seems to differ and to
depend on the cell type. We postulate a telomerase-based mechanism
for the epidermal skin keratinocytes, while dermal ﬁbroblasts and
melanocytes maintain their long telomeres due to their low proli-
feration rate.
Fig. 7. Three-dimensional analysis of telomere length on skin sections veriﬁes Southern Blot data. (A) Human skin section stained for keratin (green) marking the epidermal
keratinocytes (epidermis) and vimentin (blue) marking the ﬁbroblasts in the dermis as well as melanocytes (marked with arrows) in the basal layer of the epidermis. The telomeres,
hybridized with a telomere-speciﬁc PNA probe, are presented in red. Epidermis and dermis are indicated. (B) Graphic presentation of the mean telomere signal intensities of
keratinocytes (green), melanocytes (blue), and dermal ﬁbroblasts (grey) in skins from different-age donors, demonstrates that telomeres in the proliferating keratinocytes are
generally shorter than in the non-proliferating melanocytes or dermal ﬁbroblasts but that all exhibit similar regression slopes. The respective donor age is indicated (X-axis). (C)
Human skin stained for keratin (epidermis in green), vimentin (dermis in blue) and telomeres (telomere-speciﬁc PNA probe in red). The epidermis is divided by dotted lines into
basal, suprabasal, and upper layers (as indicated). (D) Graphic presentation of the mean telomere signal intensities and standard error of the mean in basal (light green), suprabasal
(dark green), and upper layers (black) of the epidermis of different age donors. (E) Telomere restriction fragment length analysis demonstrates a signiﬁcant age-dependent telomere
decline in peripheral blood leukocytes (PBL) from different-age members of two related families (right and left panel). (F) Their telomere lengths show a statistically signiﬁcant age-
dependent decline (pvalue of 0.0010). In all Southern blots, HaCaT cells (H) with a stable mean TRFL of 4 kb were included as control as was the size markers λHind III).
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the epidermal tissue
In line with the differences in telomere length regulation in the
epidermis in situ and in keratinocytes in conventional cultures we also
ﬁnd a clear difference in telomerase regulation. Telomerase is
expressed when the keratinocytes grow as an epidermis either in
situ or in organotypic cultures but is inhibited in monolayer culture.
Since proliferation is ongoing under both conditions, actually, proli-
feration is increased in monolayer culture as compared to the epider-
mis in situ, telomerase is not constitutively active in the keratinocytes
and accordingly dispensable for keratinocyte growth. But it is
obviously crucial in the tissue context. This said, it is noteworthy
that the epidermis is a tissue that is highly prone to stress and damage.
It is, therefore, tempting to hypothesize that besides counteracting
proliferation-dependent telomere loss telomerase may similarly be
essential for counteracting damage-dependent telomere loss in order
to maintain epidermal tissue integrity and maintenance throughout
life time.
Our data suggest that epigenetic remodelling of the hTERT
promoter is an important regulatory step in the concert of tissue-
dependent telomerase activation in human epidermis. While histone
acetylation correlates with an active hTERT promoter in freshly
isolated or early passage keratinocytes, hTERT is silenced upon
passaging in monolayer culture and this in turn correlates with its
promoter deacetylation. In organotypic cultures the hTERT promoter
became reacetylated and accordingly telomerase re-expressed.
Furthermore, keratinocytes in monolayer cultures re-expressed
telomerase activity when treated with the deacetylation inhibitor
FK228. It was recently shown that hTERT was hypoacetylated in
human mesenchymal stem cells (hMSC) in culture and that
telomerase could be reactivated by the deacetylation inhibitor
Trichostatin A [40]. This may implicate that also in these cells hTERT
is acetylated and active in vivo and that the observed deacetylation
could be a “culture”-dependent trait as we suggest for the human
epidermal keratinocytes.
Histone deacetylation coupled with a gradual accumulation of
hTERT promoter methylation was reported previously for differentia-
tion-dependent hTERT/telomerase repression in the human HT
teratocarcinoma, human HL60 acute myeloid leukaemia cells, and
mouse embryonic stem cells [41]. Our ﬁnding that histone acetylation
plays a role in the tissue context-dependent telomerase regulation
supports the idea that histone acetylation/deacetylation regulate
telomerase activity in physiological processes. Importantly, this type
of regulation also allows for downstream regulatory processes. EGF
was reported to be a potent telomerase activator, stimulating hTERT
transcription through an ets motive in the hTERT promoter [27] and
that withdrawal of EGF or amphiregulin inhibited telomerase activity
in culture [42]. In our experiments EGF was not able to induce telo-
merase activity but this can now be explained by hTERT promoter
deacetylationwhich made the hTERT promoter inaccessible for EGF in
themonolayer cultures. On the other hand, growth factors such as EGF
and TGFα play an important role in stimulating keratinocyte growth
and differentiation in the epidermis in situ [25,26]. Being active and
accessible in the tissue context, our data, therefore, do not exclude
that EGF may be part of the regulatory network controlling activation
and inhibition of hTERT/telomerase activity in the process of
epidermal regeneration and tissue homeostasis.
Altogether, we have demonstrated that telomerase is expressed in
human epidermal keratinocytes in a tissue organization-dependent
manner and that in the epidermis from skin from different age donors
this expression is correlated with an only minor age-dependent
telomere loss. This suggests that telomerase is functionally active and
acts as a telomere lengths maintenance mechanism in human
epidermis. Since the corresponding melanocytes and dermal ﬁbro-
blasts show a similar low rate of telomere loss, we have to concludethat the overall telomere erosion is obviously not a driving force of
skin aging. As we also show that telomerase is inhibited in monolayer
cultures, telomere maintenance is not a constitutive trait but is
extrinsically regulated. We provide evidence that part of this regu-
latory program is hTERT promoter acetylation, thereby guaranteeing
an active hTERT transcription in the epidermis. In monolayer cultures,
on the other hand, hTERT is silenced by histone deacetylation causing
telomerase inhibition and accordingly a more extensive replication-
dependent telomere loss. Therefore, our results support our hypoth-
esis that telomerase is not required for proliferation per se but is part
of the regulatory network required for life-long epidermal tissue
regeneration.
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